AZD-7762 50 mg | 99.17%
TargetMol
AZD-7762, an effective and specific inhibitor of Chk1（IC50=5 nM）, is equally potent against Chk2 and less potent against CAM, Yes, Fyn, Lyn, Hck and Lck.
More Information Supplier PageAZD-7762
Search Results
AZD-7762 10 mg | 99.17%
TargetMol
AZD-7762, an effective and specific inhibitor of Chk1（IC50=5 nM）, is equally potent against Chk2 and less potent against CAM, Yes, Fyn, Lyn, Hck and Lck.
More Information Supplier PageAZD-7762
UMI-77 5 mg | Purity Not Available
TargetMol
UMI-77, a specific Mcl-1 inhibitor (Ki: 490 nM), has selectivity over other members of Bcl-2 family.
More Information Supplier PageUMI-77
UMI-77 50 mg | Purity Not Available
TargetMol
UMI-77, a specific Mcl-1 inhibitor (Ki: 490 nM), has selectivity over other members of Bcl-2 family.
More Information Supplier PageUMI-77
UMI-77 10 mg | Purity Not Available
TargetMol
UMI-77, a specific Mcl-1 inhibitor (Ki: 490 nM), has selectivity over other members of Bcl-2 family.
More Information Supplier PageUMI-77
GSK1324726A 5 mg | 98.34%
TargetMol
GSK1324726A is a greatly specific inhibitor of BET family proteins for BRD2(IC50=41 nM), BRD3(IC50=31 nM), and BRD4 (IC50=22 nM).
More Information Supplier PageGSK1324726A
CID5721353 5 mg | Purity Not Available
TargetMol
CID5721353 is a B-Cell Lymphoma 6 Inhibitor (BCL6 inhibitor) that disrupts BCL6/corepressor complexes in vitro and in vivo, and was shown to bind the critical site within the BTB groove.
More Information Supplier PageCID5721353
CID5721353 50 mg | Purity Not Available
TargetMol
CID5721353 is a B-Cell Lymphoma 6 Inhibitor (BCL6 inhibitor) that disrupts BCL6/corepressor complexes in vitro and in vivo, and was shown to bind the critical site within the BTB groove.
More Information Supplier PageCID5721353
CID5721353 25 mg | Purity Not Available
TargetMol
CID5721353 is a B-Cell Lymphoma 6 Inhibitor (BCL6 inhibitor) that disrupts BCL6/corepressor complexes in vitro and in vivo, and was shown to bind the critical site within the BTB groove.
More Information Supplier PageCID5721353
CID5721353 10 mg | Purity Not Available
TargetMol
CID5721353 is a B-Cell Lymphoma 6 Inhibitor (BCL6 inhibitor) that disrupts BCL6/corepressor complexes in vitro and in vivo, and was shown to bind the critical site within the BTB groove.
More Information Supplier PageCID5721353